"Next Generation Sequencing (NGS) Market Summary:
According to the latest report published by Data Bridge Market Research, the Next Generation Sequencing (NGS) Market
CAGR Value
- The global next generation sequencing (NGS) market was valued at USD 15.98 billion in 2024 and is expected to reach USD 49.21 billion by 2032
- During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 15.10%, primarily driven by continuous advancements in sequencing technologies and increasing clinical applications
The large scale Next Generation Sequencing (NGS) Marketing report studies and evaluates market drivers, market restraints, challenges, opportunities and key developments in the market. SWOT analysis has been used throughout the report which helps emphasize on the global key manufacturers, market definition, description and analysis of the market competition landscape. The market research data included in this Next Generation Sequencing (NGS) Market report is analysed and forecasted using market statistical and coherent models. It makes effortless for Next Generation Sequencing (NGS) Market industry to visualize what is already available in the market, what market anticipates, the competitive environment, and what should be done to surpass the competitor. This results into actionable ideas, better decision-making and better business strategies.
Stay informed with our latest keyword market research covering strategies, innovations, and forecasts. Download full report: https://www.databridgemarketresearch.com/reports/global-next-generation-sequencing-ngs-market
Next Generation Sequencing (NGS) Market Segmentation and Market Companies
Segments
- Based on technology, the NGS market can be segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, sequencing by ligation (SBL), pyrosequencing, single-molecule real-time (SMRT) sequencing, and others. Sequencing by synthesis technology is expected to dominate the market due to its high accuracy and efficiency in DNA sequencing.
- On the basis of application, the market can be divided into diagnostics, drug discovery, precision medicine, genetic screening, agriculture & animal research, and others. The diagnostics segment is expected to witness significant growth, driven by the increasing demand for personalized medicine and early disease detection.
- By end-user, the NGS market can be categorized into academic research centers, pharmaceutical & biotechnology companies, hospitals & clinics, and others. The pharmaceutical & biotechnology companies are expected to hold a major share in the market due to their focus on developing precision medicine solutions.
Market Players
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Qiagen
- F. Hoffmann-La Roche AG
- Agilent Technologies, Inc.
- BGI
- Bio-Rad Laboratories, Inc.